Zhongchao Inc. Announces Its Patient Management System Improves Its Liver Cancer Patients’ Duration of Therapy by 40%, Promoting Successful Treatment
SHANGHAI, Oct. 29, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced its self-developed patient management system improves Duration of Therapy ("DOT") by 40.4% for liver cancer patients, which contributes to the...
China’s New Regulation on Internet Healthcare will Benefit Platforms like WeDoctor
HANGZHOU, China, Oct. 29, 2021 /PRNewswire/ -- On 27 October, China's National Health Commission (NHC), the authority responsible for the medical industry, issued a new policy that calls for the regulation of China's fast-growing Internet healthcare industry. The policy is expected to push China's internet healthcare industry into the era of standardized development. According to the NHC, as of...
Operating Income of Yiling Pharmaceutical in First 3 Quarters Reaches CNY 8.112 Billion, Up 25.81%
SHIJIAZHUANG, China, Oct. 29, 2021 /PRNewswire/ -- Yiling Pharmaceutical released the three-quarter report on the evening of October 28. In the first three quarters, the operating income of the company reached CNY 8.112 billion, up 25.81% year on year; the net profit attributable to shareholders of the listed company hit CNY 1.224 billion, up 20.43% from the previous year,...
Over Half of ASEAN Food & Agriculture Policymakers Note Climate Change as the Top Challenge Facing Regional Food Systems
SINGAPORE, Oct. 29, 2021 /PRNewswire/ -- Initial findings officially released today highlight a key challenge raised by ASEAN food and agriculture policymakers – chiefly that more than half (51%) believe climate change is the biggest challenge regional food systems face today. This finding is part of new research that will be...
SEI & Medtrics partnership: Bringing telemedicine service to Android TV
SHENZHEN, China, Oct. 29, 2021 /PRNewswire/ -- SEI Robotics Inc, a global innovator of smart IOT devices & provider of Android TV platforms for Pay-TV operators (MVPD), announced its strategic partnership with Medtrics Inc, The Silicon Valley startup, leader of the digital health service specialized for IoT devices. The two companies are jointly developing a real-time telemedicine system with...
3M Health Care and Thermo Fisher Scientific Collaborate to Increase Process Efficiency and Scalability in Commercial Therapeutic Manufacturing
- Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers - Solution enables manufacturers to optimize manufacturing capacity, quality, efficiency and scalability ST. PAUL, Minn., Oct. 29, 2021 /PRNewswire/ -- 3M Separation and Purification Sciences announces a global agreement with Thermo Fisher Scientific that lets biopharmaceutical customers more easily...
Elekta establishes a framework for sustainability-linked bonds
STOCKHOLM, Oct. 29, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has established a Sustainability-Linked Bond Framework (SLB Framework) for issues of sustainability-linked bonds under its Medium Term Note Program (MTN-Program). Elekta is among the first companies in Sweden to establish this type of investment framework for bonds. This strengthens Elekta's sustainability focus by increasing global access to cancer...
Appendix 4C – Q1 FY22 Quarterly Cash Flow Report
Highlights: New details on ATH34 Phase 2 clinical trial released. Data from bioMUSE presented at International Parkinson and Movement Disorder Society Congress. Expanded intellectual property portfolio positions future opportunities. Cash balance as of 30 September 2021 of A$41.3M. Quarterly operating cash outflow of $4.9M as expected and...
IMPACT Therapeutics Announced ATR Inhibitor IMP9064 IND Clearance by FDA
SHANGHAI, Oct. 29, 2021 /PRNewswire/ -- IMPACT Therapeutics announced that its ATR inhibitor IMP9064 has received the IND clearance from the U.S. Food and Drug Administration (FDA) for the Phase I/II clinical study, which will begin soon in the U.S. This will be the first in human study for the ATR inhibitor of IMPACT Therapeutics, representing a major leap...
/DISREGARD RELEASE: Frontier Biotechnologies/
We are advised by Frontier Biotechnologies that journalists and other readers in Malaysia should disregard the news release, "Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients", issued on Oct. 27, 2021 by Frontier Biotechnologies over PR Newswire.
